V020-9721 Screening compound: N-({1-benzyl-2-[(2-fluorophenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-[(oxolan-2-yl)methyl]benzamide

V020-9721 Screening compound: N-({1-benzyl-2-[(2-fluorophenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-[(oxolan-2-yl)methyl]benzamide
V020-9721 Screening compound: N-({1-benzyl-2-[(2-fluorophenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-[(oxolan-2-yl)methyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-9721
N-({1-benzyl-2-[(2-fluorophenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-[(oxolan-2-yl)methyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-9721

Molecular Formula

C30H30FN3O4S (C30 H30 FN3 O4 S)

Compound Name

N-({1-benzyl-2-[(2-fluorophenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-[(oxolan-2-yl)methyl]benzamide

IUPAC name

N-({1-benzyl-2-[(2-fluorophenyl)methanesulfonyl]-1H-imidazol-5-yl}methyl)-N-[(oxolan-2-yl)methyl]benzamide

SMILES

O=C(c1ccccc1)N(CC1OCCC1)Cc(n1Cc2ccccc2)cnc1S(Cc(cccc1)c1F)(=O)=O

InChI

InChI=1S/C30H30FN3O4S/c31-28-16-8-7-14-25(28)22-39(36,37)30-32-18-26(34(30)19-23-10-3-1-4-11-23)20-33(21-27-15-9-17-38-27)29(35)24-12-5-2-6-13-24/h1-8,10-14,16,18,27H,9,15,17,19-22H2/t27-/m1/s1

InChI Key

KZZOZQJWYBXTKO-HHHXNRCGSA-N

MDL Number (MFCD)

MFCD19824492

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

547.65

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.247

Distribution Coefficient, logD

4.247

Water Solubility, LogSw

-4.12

Polar Surface Area

65.245

Acid Dissociation Constant (pKa)

20.02

Base Dissociation Constant (pKb)

-3.82

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

26.70

V020-9721 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

KRAS-Targeted Library (16000 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V020-9721 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-9721?
Check Price and Availability of V020-9721, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-9721 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-9721
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-9721
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-9721 available by request